XML 344 R115.htm IDEA: XBRL DOCUMENT v3.25.4
Share-based payments - Additional Information (Details)
1 Months Ended 3 Months Ended 12 Months Ended
Apr. 30, 2025
shares
May 31, 2024
USD ($)
shares
Jun. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
shares
program
$ / shares
Dec. 31, 2024
USD ($)
shares
$ / shares
Dec. 31, 2023
USD ($)
shares
$ / shares
Dec. 31, 2020
shares
Sep. 10, 2025
$ / shares
Mar. 31, 2025
USD ($)
Dec. 31, 2022
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Share-based payment, social security expense | $       $ (9,000,000) $ (13,000,000) $ (300,000)        
Share-based payment, excluding social security expense | $       $ 148,000,000 81,000,000 44,000,000        
Share-based payment arrangements, vesting period       4 years            
Share-based payments expense | $       $ 156,000,000 93,000,000 $ 43,000,000        
Expected dividend, share options granted | $       0            
Commercial agreement | Sales and marketing expenses                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Fair value of shares from share-based payment transactions | $       233,000,000 $ 17,900,000          
Commercial agreement | Sales and marketing expenses | Consumer acquisition services                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Fair value of shares from share-based payment transactions | $       50,000,000            
Commercial agreement | Sales and marketing expenses | Brand awareness services                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Fair value of shares from share-based payment transactions | $       $ 183,000,000            
Management                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of options granted (in shares)       8,834,736 400,065          
Weighted average fair value, granted during period (in us dollar per share) | $ / shares       $ 104            
Number of other equity instruments granted (in shares)       108,960 216,468          
Ordinary shares                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of shares entitled (in shares)       1            
Number of options granted (in shares)       299,572            
IPO, offering share (USD per share) | $ / shares       $ 40.00       $ 40.00    
Ordinary shares | Chief Executive Officer                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Amended during the year (in shares)       1,470,618            
Share options, class C                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of shares entitled (in shares)       2            
Share options, class C | Chief Executive Officer                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of options granted (in shares)       17,505,672            
Weighted average fair value, granted during period (in us dollar per share) | $ / shares       $ 91.8            
Weighted average fair value, amended during period (in us dollar per share) | $ / shares       $ 91.8            
Amended during the year (in shares)       2,941,236            
Restricted share units                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of share-based payment arrangements programs | program       2            
Share-based payment arrangements, vesting period       4 years            
Number of other equity instruments granted (in shares)       1,026,951 0 0        
Number of other equity instruments outstanding in share-based payment arrangement       998,907 0 0       0
Restricted share units | Klarna Group PLC subsidiary                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of other equity instruments granted (in shares)       123,335 22,659,832 7,081,803        
Number of other equity instruments released (in shares)       8,225,629 3,164,977 2,411,162        
Number of other equity instruments outstanding in share-based payment arrangement       14,597,215 26,411,646 10,208,104       7,988,295
Restricted share units | Ordinary shares                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of options granted (in shares)       2,563,600            
Legacy RSU Program                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Share-based payment arrangements, vesting period             4 years      
Share-based payment arrangements, vesting percentage             25.00%      
Share exchange ratio       0.25 0.25 0.24        
Legacy RSU Program | Ordinary shares                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of shares received per award vested (in shares)             1      
Klarna Group PLC RSU                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Share-based payment arrangements, vesting period       4 years            
Share-based payment arrangements, vesting percentage       25.00%            
Klarna Group PLC RSU | Ordinary shares                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of shares received per award vested (in shares)       1            
Share warrants and share options                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Share exchange ratio       12 12 12        
Number of options granted (in shares)       24,909,751 6,100,140 0        
Weighted average fair value, granted during period (in us dollar per share) | $ / shares       $ 57.0 $ 46.0 $ 0        
Weighted average fair value, amended during period (in us dollar per share) | $ / shares       $ 38.2            
Amended during the year (in shares)       1,477,164            
Number of options exercised (in shares)       2,400,000 0 0        
Share warrants and share options | Minimum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Share-based payment arrangements, vesting period       4 years            
Share warrants and share options | Maximum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Share-based payment arrangements, vesting period       5 years            
Share warrants and share options | Ordinary shares                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of shares received per award vested (in shares)       1            
KHAB Warrants                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of share options repurchased and not vested in share-ased payment arrangement (in shares)       6,456            
KHAB Warrants | Sales and marketing expenses                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Share-based payments expense | $       $ 100,000            
Warrants                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of options repurchased (in shares)       1,267,752            
Share repurchase, amount | $       $ 17,200,000            
Weighted average remaining contractual life       4 years 2 months 12 days 3 years          
Number of share options exercisable (in shares)       2,145,590 1,299,360          
Warrants | Minimum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Range of exercise prices (USD per share) | $ / shares       $ 34 $ 34          
Warrants | Maximum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Range of exercise prices (USD per share) | $ / shares       $ 51 $ 51          
Warrants | Commercial agreement                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of other equity instruments granted (in shares)       15,740,059 1,299,360          
Number of options vested (in shares)       3,910,393            
Number of options exercised (in shares)       2,400,000            
Share-based payment arrangement, requisite service period       5 years            
Share-based payments expense | $       $ 27,000,000            
Deferred expense to be recognized from share-ased payment transactions | $       $ 75,000,000            
Current tax liabilities | $                 $ 48,000,000  
Decrease in current tax liability | $     $ 22,000,000              
Warrants | Management                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of options repurchased (in shares)       17,500            
Warrants | Employee                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Employee restricted share unit program | $       $ 0            
Warrants | Klarna Group PLC subsidiary                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of options granted (in shares)       0 360,590 1,102,024        
Weighted average fair value, granted during period (in us dollar per share) | $ / shares       $ 0 $ 515.0 $ 578.0        
Weighted average fair value, amended during period (in us dollar per share) | $ / shares       $ 0            
Amended during the year (in shares)       0            
Number of options exercised (in shares)       90,000 126,580 65,346        
Number of options repurchased (in shares)       105,646            
Weighted average remaining contractual life       1 year 10 months 24 days 2 years 8 months 12 days 3 years 6 months        
Number of share options exercisable (in shares)       0 40,000 51,500        
Weighted average fair value at measurement date, share options granted | $         $ 17 $ 16        
Warrants | Klarna Group PLC subsidiary | Minimum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Range of exercise prices (USD per share) | $ / shares       $ 0.10 $ 0.10 $ 0.10        
Warrants | Klarna Group PLC subsidiary | Maximum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Range of exercise prices (USD per share) | $ / shares       $ 1,508 $ 1,508 $ 1,508        
Warrants | Ordinary shares                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of options exercised (in shares)       2,400,000            
Warrants | Ordinary shares | Commercial agreement                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of shares received per award vested (in shares)       1 1          
Share options                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Share-based payment arrangements, vesting period       4 years            
Weighted average remaining contractual life       3 years 4 months 24 days 3 years 7 months 6 days          
Number of share options exercisable (in shares)       2,935,177 1,460,856          
Weighted average fair value at measurement date, share options granted | $       $ 53 $ 9          
Share options | Minimum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Range of exercise prices (USD per share) | $ / shares       $ 38 $ 38          
Share options | Maximum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Range of exercise prices (USD per share) | $ / shares       $ 114 $ 114          
Share options | Chief Executive Officer                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Amended during the year (in shares)       1,477,164            
Share options, class C                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of options granted (in shares)       17,505,672 0 0        
Weighted average fair value, granted during period (in us dollar per share) | $ / shares       $ 45.9 $ 0 $ 0        
Weighted average fair value, amended during period (in us dollar per share) | $ / shares       $ 19.1            
Amended during the year (in shares)       (2,941,236)            
Number of options exercised (in shares)       0 0 0        
Weighted average remaining contractual life       3 years 8 months 12 days            
Number of share options exercisable (in shares)       9,523,581 0          
Weighted average fair value at measurement date, share options granted | $       $ 29            
Share options, class C | Minimum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Range of exercise prices (USD per share) | $ / shares       $ 19            
Share options, class C | Maximum                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Range of exercise prices (USD per share) | $ / shares       $ 57            
Equity-related instruments, business acquisition                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of other equity instruments released (in shares)   329,484                
Weighted average fair value at measurement date, other equity instruments granted (in USD per share) | $   $ 51                
Number of other equity instruments outstanding in share-based payment arrangement         0          
Employee Equity Program                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Share-based payments expense | $           $ 0        
Number of ordinary shares held (in shares) 28,762                  
Number of ordinary shares exchanged (in shares) 1,948,166                  
Employee Equity Program | Klarna Holding AB                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of ordinary shares held (in shares)         28,762 31,122        
Number of ordinary shares exchanged (in shares)         2,347 10,693        
Employee Equity Program | Ordinary shares                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of options granted (in shares)       1,948,166            
Direct Share Issuance                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Number of other equity instruments granted (in shares)       150,760 216,468          
Direct Share Issuance | Ordinary shares                    
Disclosure of terms and conditions of share-based payment arrangement [line items]                    
Weighted average fair value at measurement date, other equity instruments granted (in USD per share) | $       $ 34 $ 34